These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33196154)

  • 1. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.
    Wood FA; Howard JP; Finegold JA; Nowbar AN; Thompson DM; Arnold AD; Rajkumar CA; Connolly S; Cegla J; Stride C; Sever P; Norton C; Thom SAM; Shun-Shin MJ; Francis DP
    N Engl J Med; 2020 Nov; 383(22):2182-2184. PubMed ID: 33196154
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.
    Gupta A; Thompson D; Whitehouse A; Collier T; Dahlof B; Poulter N; Collins R; Sever P;
    Lancet; 2017 Jun; 389(10088):2473-2481. PubMed ID: 28476288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment.
    Howard JP; Wood FA; Finegold JA; Nowbar AN; Thompson DM; Arnold AD; Rajkumar CA; Connolly S; Cegla J; Stride C; Sever P; Norton C; Thom SAM; Shun-Shin MJ; Francis DP
    J Am Coll Cardiol; 2021 Sep; 78(12):1210-1222. PubMed ID: 34531021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials.
    Herrett E; Williamson E; Brack K; Beaumont D; Perkins A; Thayne A; Shakur-Still H; Roberts I; Prowse D; Goldacre B; van Staa T; MacDonald TM; Armitage J; Wimborne J; Melrose P; Singh J; Brooks L; Moore M; Hoffman M; Smeeth L;
    BMJ; 2021 Feb; 372():n135. PubMed ID: 33627334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial.
    Kristiansen O; Vethe NT; Peersen K; Wang Fagerland M; Sverre E; Prunés Jensen E; Lindberg M; Gjertsen E; Gullestad L; Perk J; Dammen T; Bergan S; Husebye E; Otterstad JE; Munkhaugen J
    Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):507-516. PubMed ID: 32609361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.
    Herrett E; Williamson E; Beaumont D; Prowse D; Youssouf N; Brack K; Armitage J; Goldacre B; MacDonald T; Staa TV; Roberts I; Shakur-Still H; Smeeth L
    BMJ Open; 2017 Dec; 7(12):e016604. PubMed ID: 29197834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
    Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
    Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
    Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin treatment for unruptured intracranial aneurysms study: a study protocol for a double-blind, placebo-controlled trial.
    Li W; Zhang Y; Tian Z; Zhu W; Liu J; Zhang Y; Yang X; Tian DC
    Stroke Vasc Neurol; 2020 Dec; 5(4):410-415. PubMed ID: 32381630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.
    Abbasi SH; Mohammadinejad P; Shahmansouri N; Salehiomran A; Beglar AA; Zeinoddini A; Forghani S; Akhondzadeh S
    J Affect Disord; 2015 Sep; 183():149-55. PubMed ID: 26005776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atorvastatin on testosterone levels.
    Shawish MI; Bagheri B; Musini VM; Adams SP; Wright JM
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013211. PubMed ID: 33482034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of statins on skeletal muscle function.
    Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
    Circulation; 2013 Jan; 127(1):96-103. PubMed ID: 23183941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Liver Enzymes Unmask Severe Statin-Induced Muscle Injury.
    Abdallah MA; Ahmed KM; Gohar A; Abdalla AO; Waqas Q; Elgouhari H; Huntington MK
    Am J Ther; 2020; 27(4):e420-e422. PubMed ID: 31180927
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial.
    Moriarty PM; Thompson PD; Cannon CP; Guyton JR; Bergeron J; Zieve FJ; Bruckert E; Jacobson TA; Baccara-Dinet MT; Zhao J; Donahue S; Ali S; Manvelian G; Pordy R
    J Clin Lipidol; 2020; 14(1):88-97.e2. PubMed ID: 32192644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial.
    Hari P; Khandelwal P; Satpathy A; Hari S; Thergaonkar R; Lakshmy R; Sinha A; Bagga A
    Pediatr Nephrol; 2018 Dec; 33(12):2299-2309. PubMed ID: 30091061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD.
    Harris KP; Wheeler DC; Chong CC;
    Kidney Int; 2002 Apr; 61(4):1469-74. PubMed ID: 11918754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
    Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
    J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated necrotising myopathy is a rare statin-associated adverse effect: a case report.
    Lee KF; Mak MWH; Lao VWN; Yip HLK; Lau WY; Wong VTL
    Hong Kong Med J; 2020 Oct; 26(5):441-443. PubMed ID: 33089790
    [No Abstract]   [Full Text] [Related]  

  • 20. Atorvastatin-Associated DRESS Syndrome.
    Rosas Saldarriaga D; Berrouet Mejía MC
    Am J Ther; 2019; 26(5):e638-e639. PubMed ID: 30272596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.